The decision to place cochlear implants in both ears at the same time in young children may better shape brain development ...
MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.
Violet and Fearne Murray, from Workington, are raising money to give back after their cochlear implant operations. | ITV News ...
After struggling to adapt through school and adult life, Lucy was offered a new procedure at Colchester Hospital. The mum-of-three went through a major surgery, making her the first person to have the ...
Heather Porter overcame profound hearing loss and surgeries — all while raising 11 kids — to earn her master's. Her story ...
The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.
The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...
HealthDay on MSN
First gene therapy for genetic hearing loss gains FDA approval
Key Takeaways Otarmeni, a gene therapy targeting a specific mutation that causes profound deafness, now has U.S. Food and ...
The world’s first clinical trial on congenital deafness gene therapy showed that injecting a missing gene back into ear cells ...
With age comes hearing loss, and modern technology has come a long way in making sure we don't lose track of the important ...
On a day in the fall of 2022, Snohomish resident Erik Martin, who is also a police officer, woke up and found that he lost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results